Markt oder Branche auswählen:
Chart-Typ:
Zeitraum:
| Pharming Group N.V.: Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026 | Leniolisib was generally well-tolerated, with clinical improvements across multiple measures of immune dysregulation, including reductions in lymphoproliferation Separately, Pharming expects to report... ► Artikel lesen |
| Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy | Original-Research: Pharming Group NV - from First Berlin Equity Research GmbH
18.09.2026 / 11:30 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer... ► Artikel lesen |
| Pharming Group N.V.: FDA approves Pharming's Joenja as first treatment for children with APDS in the U.S. | FDA approval expands Joenja indication to include children with activated phosphoinositide 3-kinase delta (PI3Kd) syndrome (APDS) ages 4 to 11 who weigh at least 27kgNewly approved Joenja doses are... ► Artikel lesen |
| Corbion announces organic sales growth of +8.5% to €337.4m and Adjusted EBITDA of €51.0m in Q2; refines full-year margin outlook to >16% | Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes half-year 2026 results ending 30 June 2026.
Key highlights... ► Artikel lesen |
| Chair of the Supervisory Board of Corbion to step down as of 1 August 2026 | Corbion today announces that the Chair of its Supervisory Board, Ilona Haaijer, has informed the Supervisory Board that for personal reasons she has decided to step down from her position as Chair... ► Artikel lesen |
| Dividendenbekanntmachungen (15.05.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A10 NETWORKS INC US0021211018 0,06 USD 0,0514 EUR AF GRUPPEN ASA NO0003078107 6,5 NOK 0,6029 EUR AGCO CORPORATION US0010841023 0... ► Artikel lesen |
| Arcadis N.V.: Arcadis presents its 2027-2029 Business Strategy during the Capital Markets Day on the 29th of September 2026 | PRESS RELEASE
Register now!
Arcadis presents its 2027-2029 Business Strategy during the Capital Markets Day on the 29th of September 2026
Amsterdam, 9 September 2026 - Arcadis (EURONEXT:... ► Artikel lesen |
| Everbridge and Arcadis Partner to Help Organizations Assess and Manage Climate Risk | Strategic partnership combines climate risk expertise, adaptation planning, and operational resilience capabilities to help organizations reduce climate-related risk
Everbridge, the global leader... ► Artikel lesen |
| Arcadis N.V.: Arcadis share capital reduction becomes effective | PRESS RELEASE
Arcadis share capital reduction becomes effective
Amsterdam, 21 August 2026 - Arcadis (EURONEXT: ARCAD), the world's leading company delivering data-driven sustainable design,... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.